Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.7K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

37.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

3.1K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.1K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

6.1K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia rescues complex 1-associated disease caused by proteostatic defects.

Nature metabolism·2026
Same author

RNA G-quadruplexes function as a tunable switch of FUS phase separation.

Nucleic acids research·2026
Same author

Isoform-specific steric zippers drive aberrant assembly and mislocalization of shortened TDP-43.

Science advances·2026
Same author

Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration.

Science (New York, N.Y.)·2026
Same author

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.

Molecular cell·2026
Same author

Nuclear-import receptors remodel the dilute phase to suppress phase transitions of RNA-binding proteins with prion-like domains.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Nov 18, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K

Open Access: A Role for p53 in c9ALS/FTD?

Charlotte M Fare1, James Shorter1

  • 1Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA; Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Trends in Genetics : TIG
|February 8, 2021
PubMed
Summary
This summary is machine-generated.

Toxic protein poly(PR) from C9orf72 repeat expansions drives neurodegeneration in ALS/FTD by altering neuronal epigenetics and promoting cell death pathways.

Keywords:
PUMATDP-43c9ALS/FTDdipeptide-repeat proteinp53poly(PR)

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

8.9K

Related Experiment Videos

Last Updated: Nov 18, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

8.9K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Poly(PR), a toxic dipeptide-repeat protein, is translated from the G4C2 repeat expansion in C9orf72.
  • This expansion is a key genetic cause of C9orf72-associated amyotrophic lateral sclerosis/frontotemporal dementia (c9ALS/FTD).
  • The precise mechanisms by which poly(PR) causes neurodegeneration are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying poly(PR)-induced neurodegeneration.
  • To investigate the role of poly(PR) in altering neuronal epigenetics.
  • To identify downstream pathways activated by poly(PR) that lead to neuronal cell death.

Main Methods:

  • Utilized cellular and animal models relevant to c9ALS/FTD.
  • Employed techniques to assess epigenetic modifications in neurons exposed to poly(PR).
  • Investigated the activation of apoptotic pathways, including p53 and PUMA.

Main Results:

  • Poly(PR) was shown to remodel the neuronal epigenome.
  • This epigenetic remodeling promotes proapoptotic p53 activity.
  • The PUMA protein, downstream of p53, was identified as a key mediator driving neurodegeneration.

Conclusions:

  • Poly(PR) exerts its neurotoxic effects by altering the neuronal epigenome.
  • The p53-PUMA apoptotic pathway is a critical mechanism through which poly(PR) causes neurodegeneration.
  • These findings provide new insights into the pathogenesis of c9ALS/FTD and potential therapeutic targets.